Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Concomitant DOAC-Antiplatelet Use & Bleeding Risk

Am J Med; ePub 2018 Oct 25; Douros, et al

Among patients with non-valvular atrial fibrillation (AF), concomitant use of direct oral anticoagulants (DOACs) with antiplatelet agents was associated with a similar risk of gastrointestinal bleeding, and a lower risk of intracranial hemorrhage and other major bleeding than concomitant vitamin K antagonist (VKA)-antiplatelet use, a recent study found. Using computerized healthcare databases, researchers conducted a cohort study among patients newly diagnosed with non-valvular AF between January 2011 and March 2014. They found:

  • A total of 5,301 patients initiated concomitant DOAC-antiplatelet use, while 9,106 patients initiated concomitant VKA-antiplatelet use.
  • During a median follow-up of 1.6 months, concomitant DOAC-antiplatelet use was associated with a similar risk of gastrointestinal bleeding (HR, 1.08), but a decreased risk of intracranial hemorrhage (HR, 0,46), and other major bleeding (HR, 0.68) compared with concomitant VKA-antiplatelet use.
  • There were no duration-response relations for the 3 bleeding outcomes.

Citation:

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L. Concomitant use of direct oral anticoagulants with antiplatelet agents and the risk of major bleeding in patients with non-valvular atrial fibrillation. [Published online ahead of print October 25, 2018]. Am J Med. doi:10.1016/j.amjmed.2018.10.008.

This Week's Must Reads

CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al

USPSTF: Interventions to Prevent Child Maltreatment, JAMA; 2018 Nov 27; US Preventive Services Task Force

Team-Based Primary Care in Chronically Ill Patients, JAMA Intern Med; ePub 2018 Nov 26; Meyers, et al

Rotating Night Shift Work & Risk of T2D, BMJ; ePub 2018 Nov 21; Shan, Li, et al

PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al

Must Reads in Cardiology

CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al

PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al

Is Obesity Associated With Adverse CV Outcomes?, JAMA Netw Open; 2018 Nov 16; Riaz, et al

Cholesterol Guidelines Stress Lifetime Approach, Circulation; ePub 2018 Nov 10; Grundy, et al

Does Vitamin D Reduce Cancer & CVD Risk?, N Engl J Med; ePub 2018 Nov 10; Manson, et al